Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 3-3 ◽  
Author(s):  
J. O'Shaughnessy ◽  
C. Osborne ◽  
J. Pippen ◽  
M. Yoffe ◽  
D. Patt ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Annual Meeting ◽  
Clinical Oncology ◽  
Phase Ii ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Phase Ii Trial ◽  
Randomized Phase Ii ◽  
Final Text

3 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. [Table: see text]

Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. CRA501-CRA501 ◽  
Author(s):  
A. Tutt ◽  
M. Robson ◽  
J. E. Garber ◽  
S. Domchek ◽  
M. W. Audeh ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Annual Meeting ◽  
Clinical Oncology ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Parp Inhibitor ◽  
Advanced Breast ◽  
Final Text

CRA501 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. [Table: see text]

Multicenter, randomized phase II trial of GM-CSF (GM) plus ipilimumab (Ipi) versus ipi alone in metastatic melanoma: E1608.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. CRA9007-CRA9007 ◽  
Author(s):  
F. Stephen Hodi ◽  
Sandra J. Lee ◽  
David F. McDermott ◽  
Uma N. M. Rao ◽  
Lisa H. Butterfield ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Annual Meeting ◽  
Clinical Oncology ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Daily News ◽  
Online Supplement ◽  
Gm Csf ◽  
Randomized Phase Ii ◽  
Final Text

CRA9007 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Saturday, June, 1, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News.

Sign in / Sign up

Export Citation Format

Share Document